Bio Medica Laboratories Limited (NSE:BMLL)
India · Delayed Price · Currency is INR 177.00
+14.70 (9.06%)
At close: Sep 4, 2026
Bio Medica Laboratories Revenue
In the fiscal year ending March 31, 2026, Bio Medica Laboratories had annual revenue of 430.90M INR with 12.81% growth.
Revenue
430.90M
Revenue Growth
+12.81%
P/S Ratio
5.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.23B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 430.90M | 48.95M | 12.81% |
| Mar 31, 2025 | 381.95M | 229.46M | 150.47% |
| Mar 31, 2024 | 152.49M | -9.79M | -6.03% |
| Mar 31, 2023 | 162.28M | -49.97M | -23.54% |
| Mar 31, 2022 | 212.25M | 83.00M | 64.21% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bilcare | 7.73B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.92B |
| Gennex Laboratories | 1.78B |
| Astonea Labs | 1.48B |
| Kerala Ayurveda | 1.36B |
| Oxygenta Pharmaceutical | 1.35B |
| BDH Industries | 997.10M |